Providence Wealth Advisors, LLC Pfizer Inc Transaction History

Providence Wealth Advisors, LLC

$124 Million
Q2 2024

A detailed history of Providence Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 42,702 shares of PFE stock, worth $1.17 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

42,702

Previous 41,855 2.02%

Holding current value

$1.17 Million

Previous $1.16 Million 2.84%

% of portfolio

0.96%

Previous 1.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $21,395 - $25,071	847 Added 2.02%	42,702 $1.19 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $85,074 - $97,692	3,286 Added 8.52%	41,855 $1.16 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $12,547 - $14,666	391 Added 1.02%	38,569 $1.28 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $79,825 - $92,355	-2,210 Reduced 5.47%	38,178 $1.4 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $7,405 - $9,640	188 Added 0.47%	40,388 $1.65 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $16,407 - $21,418	393 Added 0.99%	40,200 $2.06 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $52,118 - $63,623	-1,191 Reduced 2.91%	39,807 $1.89 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $80,310 - $95,223	1,726 Added 4.39%	40,998 $2.14 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $7,228 - $8,957	158 Added 0.4%	39,272 $2.03 Million
Q4 2021 Jan 12, 2022	SELL	$41.32 - $61.25 $7,933 - $11,760	-192 Reduced 0.49%	39,114 $2.16 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $43,096 - $55,361	-1,098 Reduced 2.72%	39,306 $1.67 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $8,259 - $9,356	230 Added 0.57%	40,404 $1.6 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $38,346 - $43,246	1,145 Added 2.93%	40,174 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $57,702 - $73,373	1,724 Added 4.62%	39,029 $1.43 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $429,641 - $504,067	-13,532 Reduced 26.62%	37,305 $1.37 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $13,282 - $16,114	-441 Reduced 0.86%	50,837 $1.66 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $4,216 - $6,024	156 Added 0.31%	51,278 $1.65 Million
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $71,798 - $81,482	-2,181 Reduced 4.09%	51,122 $1.99 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $12,671 - $16,430	-390 Reduced 0.73%	53,303 $1.92 Million
Q2 2019 Jul 22, 2019	SELL	$36.98 - $41.52 $7,987 - $8,968	-216 Reduced 0.4%	53,693 $2.35 Million
Q1 2019 Apr 18, 2019	BUY	$37.5 - $41.2 $26,062 - $28,634	695 Added 1.31%	53,909 $2.3 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $33,853 - $38,596	-880 Reduced 1.63%	53,214 $2.29 Million
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $11,271 - $13,671	327 Added 0.61%	54,094 $2.38 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $11,740 - $12,516	356 Added 0.67%	53,767 $1.95 Million
Q1 2018 Aug 14, 2018	BUY	$31.91 - $37.02 $1.7 Million - $1.98 Million	53,411 New	53,411 $1.87 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Account

Providence Wealth Advisors, LLC Pfizer Inc Transaction History